Shares of Aurobindo Pharma Ltd were trading in the red and 1.5% lower on 8 April after the company announced receiving three observations from USFDA....
Shares of Cipla Ltd. sank 1.51% on a routine current Good Manufacturing Practices (cGMP) inspection conducted by the United States Food and Drug Administration (USFDA)...
Shares of Marksans Pharma gained more than 7% in trade on Friday after the company announced that its subsidiary received the Establishment Inspection Report from...
Cipla shares fell as much as 2% during the trading session on 21 September after InvaGen Pharmaceuticals, its wholly-owned subsidiary, received 5 inspectional observations from...
Aurobindo Pharma’s shares were trading in the red after the company’s subsidiary, APL Healthcare Limited, on 20 September received a ‘Form 483’ with one observation...
Solara Active Pharma Science, Cuddalore facility has been issued Form-483 with zero observation from the USFDA (the United States Food and Drug Administration). The USFDA...
Cipla’s Pithampur Manufacturing Facility has received a current Good Manufacturing Practices (cGMP) inspection by the USFDA (the United States Food and Drug Administration) from 6...